The Clorox Company, based in Oakland, California, is an American global manufacturer and marketer of consumer and professional products.
| Revenue (TTM) | $6.76B |
| Gross Profit (TTM) | $2.96B |
| EBITDA | $1.27B |
| Operating Margin | 17.00% |
| Return on Equity | 54.60% |
| Return on Assets | 11.00% |
| Revenue/Share (TTM) | $55.32 |
| Book Value | $-0.55 |
| Price-to-Book | 46.58 |
| Price-to-Sales (TTM) | 1.73 |
| EV/Revenue | 2.215 |
| EV/EBITDA | 11.42 |
| Quarterly Earnings Growth (YoY) | 2.70% |
| Quarterly Revenue Growth (YoY) | 0.10% |
| Shares Outstanding | $120.92M |
| Float | $120.51M |
| % Insiders | 0.72% |
| % Institutions | 86.20% |
Volatility is currently contracting
OAKLAND, Calif., July 13, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) will issue its fourth-quarter and fiscal year 2026 results on August 3, 2026.
On CNBC's “Halftime Report Final Trades,” Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, named DICK'S Sporting Goods, Inc. (NYSE:DKS) as his final trade.
It's the right time to jump in on dividend stocks. Clorox, Pfizer, Verizon and Comcast are some of the names to consider.
Shares in The Clorox Company continue to struggle, with YTD losses of over 7% adding to its losses of over 25% in the past year. The declines come as the cleaning-products maker is contending with declining sales and decreasing profitability. While the challenges are real, I believe CLX can overcome them and return to positive growth.
Clorox remains a defensive dividend play, appealing to long-term income-focused investors despite recent stock weakness. I see the premium valuation as a limiting factor, suggesting potential for price consolidation rather than outperformance. Turnaround potential exists if volatility returns, economic headwinds favor staples, or growth accelerates as analysts anticipate.
Palm Valley Capital Fund acquired three new positions during the second quarter: The Clorox Company, Molson Coors Beverage Company, and Vontier Corp. We sold our position in Heartland Express during the quarter. The stocks most negatively affecting the Fund's second quarter return were Amdocs, LKQ, and Chord Energy.
Every month, we screen for dividend growth stocks, highlighting value and income opportunities with high safety, growth, and consistency quant grades. There are several blue-chip names that have populated near the top of the list as potential turnaround plays. We also have a small retail-focused REIT being brought up this month that could be an interesting potential acquisition target for larger players.
OAKLAND, Calif., June 17, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced a simplified operating structure designed to streamline leadership oversight, align resources to drive the company's strongest growth opportunities, advance portfolio optimization efforts and support faster execution across the enterprise to improve business performance.
#TheMorningFilter #PortfolioRebalance #StockInvesting These value stocks can balance portfolios heavy in growth stocks—and they're undervalued, too. Watch The Morning Filter: https://www.youtube.com/live/aZZpyIILz3E?si=2QmG7OPY-biqvACZ 00:00:00 Introduction 00:00:32 Bristol-Myers Squibb BMY 00:01:09 Clorox CLX 00:02:50 Lockheed Martin LMT Watch more from Morningstar: 2 Overpriced Stocks to Sell https://youtu.be/2cDEjYfOvKI?si=3eirkC5_eHvZVWzT Ignore the Noise: These 2 Undervalued Stocks Could Be Winners https://www.youtube.com/watch?v=J07j3bAG2_g 3 More Stocks to Buy After Earnings https://www.youtube.com/watch?v=wB9mWstXyuA&t=21s Follow Morningstar on social: Facebook: https://www.facebook.com/MorningstarInc/ X: https://x.com/MorningstarInc Instagram https://www.instagram.com/morningstarinc/?hl=en LinkedIn: https://www.linkedin.com/company/5161/
Few consumer staples have been treated as roughly by the higher-for-longer rate regime as Clorox (NYSE:CLX | CLX Price Prediction).
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CLX and any ticker you trade — then tracks every position and per-strategy win rate.
